Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
9441
<i>E</i>. <i>chaffeensis</i> TRP120 HECT E3 Ub ligase activity mediates K48 ubiquitination and degradation of FBW7.
Published 2020“…<p><b>A.</b> Levels of FBW7 decrease in HeLa cells ectopically expressing TRP120-GFP at 0, 24, and 48 hours post transfection (hpt). …”
-
9442
-
9443
-
9444
Changes of echocardiographic data.
Published 2024“…Follow-up studies after a minimum of 6 months demonstrated a significant increase in E’ velocity (<i>P</i> = 0.035), improved EF (<i>P</i> = 0.010), and LV GLS (<i>P</i> = 0.001), and a decreased E<sub>A</sub>I (<i>P</i> = 0.025) only in the CR group. …”
-
9445
Baseline hemodynamic data.
Published 2024“…Follow-up studies after a minimum of 6 months demonstrated a significant increase in E’ velocity (<i>P</i> = 0.035), improved EF (<i>P</i> = 0.010), and LV GLS (<i>P</i> = 0.001), and a decreased E<sub>A</sub>I (<i>P</i> = 0.025) only in the CR group. …”
-
9446
Changes of hemodynamic data.
Published 2024“…Follow-up studies after a minimum of 6 months demonstrated a significant increase in E’ velocity (<i>P</i> = 0.035), improved EF (<i>P</i> = 0.010), and LV GLS (<i>P</i> = 0.001), and a decreased E<sub>A</sub>I (<i>P</i> = 0.025) only in the CR group. …”
-
9447
Baseline characteristics of patients.
Published 2024“…Follow-up studies after a minimum of 6 months demonstrated a significant increase in E’ velocity (<i>P</i> = 0.035), improved EF (<i>P</i> = 0.010), and LV GLS (<i>P</i> = 0.001), and a decreased E<sub>A</sub>I (<i>P</i> = 0.025) only in the CR group. …”
-
9448
Baseline echocardiographic data.
Published 2024“…Follow-up studies after a minimum of 6 months demonstrated a significant increase in E’ velocity (<i>P</i> = 0.035), improved EF (<i>P</i> = 0.010), and LV GLS (<i>P</i> = 0.001), and a decreased E<sub>A</sub>I (<i>P</i> = 0.025) only in the CR group. …”
-
9449
-
9450
Minimal raw clinical data with anonymization.
Published 2024“…Follow-up studies after a minimum of 6 months demonstrated a significant increase in E’ velocity (<i>P</i> = 0.035), improved EF (<i>P</i> = 0.010), and LV GLS (<i>P</i> = 0.001), and a decreased E<sub>A</sub>I (<i>P</i> = 0.025) only in the CR group. …”
-
9451
-
9452
-
9453
-
9454
-
9455
-
9456
-
9457
-
9458
-
9459
-
9460